Louise Rodino Klapac Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Louise Rodino Klapac is President, R&D and Tech Ops of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 224,030 shares of SRPT, which is worth approximately $4.21 Million. The most recent transaction as insider was on Mar 01, 2022, when has been sold 572 shares (Common Stock) at a price of $75.05 per share, resulting in proceeds of $42,929. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 224K
2.0% 3M change
231.26% 12M change
Total Value Held $4.21 Million

Louise Rodino-Klapac Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2022
SELL
Payment of exercise price or tax liability
$42,929 $75.05 p/Share
572 Reduced 0.87%
65,327 Common Stock
Nov 24 2021
BUY
Open market or private purchase
$299,867 $79.33 p/Share
3,780 Added 5.44%
65,678 Common Stock
Nov 16 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 39.25%
61,898 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 40.36%
22,169 Common Stock
LR

Louise Rodino Klapac

President, R&D and Tech Ops
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT